International Regulatory Consulting Experience

With over 90 completed and ongoing projects for more than 70 client companies, Orphix has extensive regulatory consulting experience and a proven track record of delivering successful outcomes for clients in the European and North American markets.

Therapeutic areas of expertise include: sickle cell disease; musculoskeletal conditions; rheumatology; oncology; infectious and immunological diseases; dermatology; cardiology; nephrology; metabolic diseases; respiratory diseases; neurological diseases; gene therapy and cell therapy.

Product area expertise encompasses: recombinant proteins; vaccines; growth factors; cytokines; monoclonal antibodies; blood products; synthetic biological products; siRNA medicines; new chemical entities and combination products (drug and device combinations).